文献速递眼底病与葡萄膜炎青光眼

Rho激酶抑制剂利帕舒地尔(K-115)对内毒素诱导的大鼠葡萄膜炎的抗炎作用

The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

本研究在大鼠内毒素诱导的葡萄膜炎模型中,于脂多糖注射前后腹腔给予利帕舒地尔,发现其显著减少房水浸润细胞和蛋白渗出,并抑制虹膜睫状体与视网膜的炎症因子表达及NF-κB核转位。

要点

  • 利帕舒地尔显著减少内毒素诱导的葡萄膜炎大鼠房水中的浸润细胞和蛋白渗出。
  • 利帕舒地尔抑制虹膜睫状体与视网膜中IL-1β、IL-6、TNF-α、MCP-1等炎症介质的mRNA表达。
  • 利帕舒地尔抑制RAW264.7细胞中MCP-1产生和NF-κB核转位。

核心结论

  • Rho/ROCK通路参与内毒素诱导的葡萄膜炎中黏附分子表达和炎症细胞浸润,利帕舒地尔是对急性葡萄膜炎及可能包括葡萄膜炎性青光眼在内的眼部炎症疾病有效的抗炎药。

研究设计与样本

  • 大鼠内毒素诱导的葡萄膜炎模型:脂多糖足垫注射诱导,利帕舒地尔于脂多糖注射前1小时和注射后腹腔给药。
  • 注射后24小时收集房水,检测浸润细胞、蛋白浓度和MCP-1水平,并评估虹膜睫状体浸润细胞和视网膜血管黏附白细胞。
  • 检测视网膜和虹膜睫状体中IL-1β、IL-6、TNF-α、MCP-1的mRNA水平。
  • 小鼠巨噬细胞系RAW264.7在有无利帕舒地尔存在下经脂多糖刺激,分析MCP-1表达和NF-κB核转位。

主要发现

  • 利帕舒地尔显著减少内毒素诱导的葡萄膜炎大鼠房水中的浸润细胞和蛋白渗出,并减少虹膜睫状体浸润细胞和视网膜血管黏附白细胞。
  • 利帕舒地尔抑制房水中MCP-1蛋白水平以及虹膜睫状体和视网膜中IL-1β、IL-6、TNF-α、MCP-1和细胞间黏附分子-1的mRNA水平。
  • 利帕舒地尔抑制RAW264.7细胞中MCP-1产生和NF-κB核转位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the anti-inflammatory properties of ripasudil, a Rho kinase (ROCK) inhibitor, using endotoxin-induced uveitis (EIU) in rats. METHODS: Endotoxin-induced uveitis was induced by footpad injection of lipopolysaccharide (LPS). Ripasudil was administered intraperitoneally 1 hour before and after LPS injection. The aqueous humor was collected 24 hours after injection, and the infiltrating cells, protein concentration, and levels of monocyte chemotactic protein-1 (MCP-1) were determined. Infiltrating cells in the iris ciliary body (ICB) and adherent leukocytes in retinal vessels were evaluated. The mRNA levels of IL-1β, IL-6, TNF-α, and MCP-1 in the retina and ICB were determined. A mouse macrophage cell line, RAW264.7, was stimulated with LPS in the presence or absence of ripasudil, and the expression of MCP-1 and nuclear translocation of nuclear factor (NF)-κB was analyzed. RESULTS: Ripasudil significantly reduced infiltrating cells and protein exudation in the aqueous humor, as well as the number of infiltrating cells in the ICB and adherent leukocytes in retinal vessels in EIU. Additionally, the protein level of MCP-1 in the aqueous humor and mRNA levels of IL-1β, IL-6, TNF-α, MCP-1, and intercellular adhesion molecule-1 in the ICB and retina were suppressed by ripasudil. The production of MCP-1 and nuclear translocation of NF-κB in RAW264.7 cells were also suppressed by ripasudil. CONCLUSIONS: The Rho/ROCK pathway plays a role in adhesion molecule expression and inflammatory cell infiltration in EIU, and ripasudil is a potent anti-inflammatory agent against ocular inflammatory diseases, including acute uveitis and possibly uveitic glaucoma.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Uchida T, Honjo M, Yamagishi R, et al. The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats. Invest Ophthalmol Vis Sci. 2017. PMID: 29084331. doi:10.1167/iovs.17-22679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。